首页/数据集/Studies of PDPN-targeting inhibitory peptide CY12-RP2 on B16-F10 cells.

Studies of PDPN-targeting inhibitory peptide CY12-RP2 on B16-F10 cells.

NIAID Data Ecosystem2026-05-10 收录

黑色素瘤靶向治疗

肽抑制转录组学

数据链接：

https://www.ncbi.nlm.nih.gov/sra/SRP655896 数据链接链接失效反馈

官方服务：

资源简介：

RNA-seq was performed on B16-F10 cells treated with CY12-RP2 and untreated controls.

应用场景：

创建时间：

2025-12-20

黑色素瘤靶向治疗

肿瘤耐药机制

FDA-approved BRAF inhibitors produce high response rates and improve overall survival in patients with BRAF V600E/K mutant melanoma, but are linked to pathologies associated with paradoxical ERK1/2 ac

NIAID Data Ecosystem70

The Novel Gamma Secretase Inhibitor RO4929097 Reduces the Tumor Initiating Potential of Melanoma

黑色素瘤靶向治疗

NOTCH信号通路分析

Several reports have demonstrated a role for aberrant NOTCH signaling in melanoma genesis and progression, prompting us to explore if targeting this pathway is a valid therapeutic approach against mel

NIAID Data Ecosystem40

RNA-Seq analysis of the impact of a kinase NIK inhibitor (DMBP5) on the human melanoma cell line A375

黑色素瘤靶向治疗

RNA-seq转录组学

Introduction: there is growing evidence that the IFN- -related cytokine signature plays a major role supporting the effect of pharmacological blockade of immune checkpoints. The expression of IFN-

NIAID Data Ecosystem20

Supplementary Dataset S3 from Loss of NF1 in Melanoma Confers Sensitivity to SYK Kinase Inhibition

黑色素瘤靶向治疗

激酶抑制剂敏感性

Supplementary Dataset S3

NIAID Data Ecosystem50

LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition

黑色素瘤靶向治疗

LKB1-SIK2信号通路

Metastatic uveal melanomas are highly resistant to all existing treatments. To address this critical issue, we performed a genome-wide CRISPR-Cas9 knockout screen, which revealed the LKB1-SIK2 module

NIAID Data Ecosystem20

Studies of PDPN-targeting inhibitory peptide CY12-RP2 on B16-F10 cells.

资源简介：

相关数据集